St.Shine Optical Co.,Ltd. (TPEX:1565)
Taiwan · Delayed Price · Currency is TWD 142.50
0.00 (0.00%)
Sep 5, 2025, 1:30 PM CST
St.Shine Optical Revenue
St.Shine Optical had revenue of 1.06B TWD in the quarter ending June 30, 2025, with 6.14% growth. This brings the company's revenue in the last twelve months to 4.62B, up 7.89% year-over-year. In the year 2024, St.Shine Optical had annual revenue of 4.55B with 3.55% growth.
Revenue (ttm)
4.62B
Revenue Growth
+7.89%
P/S Ratio
1.55
Revenue / Employee
1.25M
Employees
3,698
Market Cap
7.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.55B | 156.17M | 3.55% |
| Dec 31, 2023 | 4.39B | -609.61M | -12.18% |
| Dec 31, 2022 | 5.00B | -398.11M | -7.37% |
| Dec 31, 2021 | 5.40B | 395.02M | 7.89% |
| Dec 31, 2020 | 5.01B | -1.34B | -21.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Lumosa Therapeutics | 37.25M |
| Oneness Biotech | 112.57M |
| Center Laboratories | 1.60B |
| Polaris Group | 64.02M |